Release Date: 02/09/19 09:22 Summary: Investor Presentation and Business Update Price Sensitive: Yes Download Document 2.69MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%